Tag: biotechnology
-
First Blood Disorder Crispr Treatments Reported
Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatments helped patients improve their conditions.
-
T-Cells Engineered to Release Anti-Cancer Proteins
A biotechnology company is developing modified immune system cells programmed to sense and respond to cancer cells with targeted therapeutic proteins.
-
New Company Using A.I. to Discover Mental Health Drugs
A new enterprise combining resources from biotechnology and artificial intelligence aims to find safer and more effective treatments for psychiatric disorders.
-
Phone-Based Infectious Disease Diagnostics Being Developed
An engineering lab is building a system for diagnosing viral infectious diseases with blood samples analyzed by a smartphone add-on.
-
Engineered Organ Transplant Company Raises New Funds
An enterprise that applies gene editing to create replacement organs from pigs for human transplant is raising $100 million in new venture financing.
-
Gene Therapy Combo Treats Multiple Age-Related Diseases
A bio-engineering team shows a single experimental gene therapy cocktail can reduce or reverse four age-related diseases in lab mice.
-
Partnership to Assess Digital Gut Disease Treatments
A digital therapeutics enterprise and a company developing therapies for intestinal disorders are evaluating the potential of digital treatments for gut diseases.
-
MD Anderson, Biotech Partner on T-Cell Receptors
A cancer center and biotechnology company are creating treatments that target proteins on immune-system cells unique to each patient.
-
Trial Shows Nanotech Drug Induces Gluten Tolerance
Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease.
-
Infographic – Biotech Index Decline Continues
The NBI is in decline since reaching its peak for the year in the spring, erasing all of the gains for the year at the beginning of October.